89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma
Clinical trial NCT04006522 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04006522
- Sponsor
- James Brugarolas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2025-10-07
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.